Rentokil Initial (RTO) Stock Price, News & Analysis

Company Overview

Rentokil Initial plc (NYSE:RTO) is a business services company headquartered in the United Kingdom. It provides pest control, hygiene, and workplace services to commercial, public-sector, and residential customers. Its offerings are designed to help organizations manage pests, maintain sanitary environments, and support health, safety, and workplace standards.

The company’s pest control services address insects, rodents, and other pests, while its hygiene operations provide washroom services, sanitary products, air care, floor-care solutions, and related workplace services. Rentokil Initial also offers interior landscaping and plant-care services through its Ambius business. Its principal brands include Rentokil, Initial, and Ambius, and the company expanded its pest control presence in North America through the acquisition of Terminix.

Rentokil Initial traces its history to businesses established in the early twentieth century, including Rentokil and Initial, which combined in 1996. The company serves customers across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa through a broad international operating network.

Key Stats

• Today's Range: $20.79 to $21.28
• 50-Day Range: $19.77 to $24.57
• 52-Week Range: $19.50 to $34.67
• Volume: 1.64 million shs
• Average Volume: 1.40 million shs
• Market Capitalization: $10.74 billion
• P/E Ratio: N/A
• Dividend Yield: 1.65%
• Price Target: $31.90
• Consensus Rating: Hold

Rentokil Initial Stock Analysis - MarketRank™

Rentokil Initial scored higher than 65% of companies evaluated by MarketBeat, and ranked 375th out of 654 stocks in the industrials sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.2 / 5
• Analyst Rating: Hold

Consensus Rating

Rentokil Initial has received a consensus rating of Hold. The company's average rating score is 2.38, and is based on no strong buy ratings, 7 buy ratings, 4 hold ratings, and 2 sell ratings.

Upside Potential

Rentokil Initial has a consensus price target of $31.90, representing about 51.5% upside from its current price of $21.06.

Amount of Analyst Coverage

Rentokil Initial has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: 6.60%

Earnings Growth

Earnings for Rentokil Initial are expected to grow by 6.60% in the coming year, from $1.06 to $1.13 per share.

Price to Earnings Growth Ratio

Rentokil Initial has a PEG Ratio of 3.07. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Rentokil Initial has a P/B Ratio of 1.94. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.64% of the float of Rentokil Initial has been sold short.

Short Interest Ratio / Days to Cover

Rentokil Initial has a short interest ratio ("days to cover") of 1.28, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Rentokil Initial has recently decreased by 1.26%, indicating that investor sentiment is improving.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Rentokil Initial pays a meaningful dividend of 1.72%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Rentokil Initial does not have a long track record of dividend growth.

Dividend Sustainability

Based on earnings estimates, Rentokil Initial will have a dividend payout ratio of 30.97% next year. This indicates that Rentokil Initial will be able to sustain or increase its dividend.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: 0.00

News Coverage This Week

MarketBeat has tracked 2 news articles for Rentokil Initial this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for RTO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

MarketBeat Follows

2 people have added Rentokil Initial to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 0.1 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Rentokil Initial insiders have not sold or bought any company stock.

Percentage Held by Institutions

9.91% of the stock of Rentokil Initial is held by institutions.

Company Calendar

• Last Earnings: 8/06/2020
• Record date for 9/22 Dividend: 8/14/2026
• Ex-Dividend for 9/22 Dividend: 8/14/2026
• Dividend Payable: 9/22/2026
• Today: 10/19/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Industrials
• Industry: Commercial Services & Supplies
• Sub-Industry: Environmental & Facilities Services
• Current Symbol: NYSE:RTO
• CIK: 930157
• Web: www.rentokil-initial.com
• Phone: 441293858000
• Fax: N/A
• Employees: 63,388
• Year Founded: 1925

Price Target and Rating

• Average Price Target for Rentokil Initial: $31.90
• High Price Target: $35.00
• Low Price Target: $26.70
• Potential Upside/Downside: +50.1%
• Consensus Rating: Hold
• Rating Score (0-4): 2.38
• Research Coverage: 13 Analysts

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 20.05
• P/E Growth: 3.07
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 0.65
• Current Ratio: 1.06
• Quick Ratio: 0.98

Sales & Book Value

• Annual Sales: $7.13 billion
• Price / Sales: 1.51
• Cash Flow: $2.35 per share
• Price / Cash Flow: 9.03
• Book Value: $10.88 per share
• Price / Book: 1.95

Miscellaneous

• Outstanding Shares: 505,208,000
• Free Float: N/A
• Market Cap: $10.74 billion
• Optionable: Not Optionable
• Beta: 1.01